galactose has been researched along with Acute-On-Chronic Liver Failure (ACLF) in 1 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 1 (100.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Chakrabarti, A; Chawla, YK; Dhiman, RK; Duseja, A; Singh, S; Singh, V; Taneja, S; Verma, N | 1 |
1 other study(ies) available for galactose and Acute-On-Chronic Liver Failure (ACLF)
Article | Year |
---|---|
Invasive fungal infections amongst patients with acute-on-chronic liver failure at high risk for fungal infections.
Topics: Acute-On-Chronic Liver Failure; Adult; Aged; Antifungal Agents; beta-Glucans; Biomarkers; Female; Galactose; Humans; India; Invasive Fungal Infections; Male; Mannans; Middle Aged; Predictive Value of Tests; Prevalence; Prognosis; Proteoglycans; Retrospective Studies; Risk Assessment; Risk Factors | 2019 |